Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

The role of multiparametric MRI in biopsy-naive prostate cancer.

Lebastchi AH, Pinto PA.

Nat Rev Urol. 2019 May;16(5):276-277. doi: 10.1038/s41585-019-0173-7. No abstract available.

PMID:
30914803
2.

The role of the multiparametric MRI in the diagnosis of prostate cancer in biopsy-naïve men.

Rhudd A, McDonald J, Emberton M, Kasivisvanathan V.

Curr Opin Urol. 2017 Sep;27(5):488-494. doi: 10.1097/MOU.0000000000000415. Review.

PMID:
28562371
3.

Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature.

Fütterer JJ, Briganti A, De Visschere P, Emberton M, Giannarini G, Kirkham A, Taneja SS, Thoeny H, Villeirs G, Villers A.

Eur Urol. 2015 Dec;68(6):1045-53. doi: 10.1016/j.eururo.2015.01.013. Epub 2015 Feb 2. Review.

PMID:
25656808
4.

Multiparametric MRI and targeted prostate biopsy: Improvements in cancer detection, localization, and risk assessment.

Bjurlin MA, Mendhiratta N, Wysock JS, Taneja SS.

Cent European J Urol. 2016;69(1):9-18. doi: 10.5173/ceju.2016.734. Epub 2016 Jan 25. Review.

5.

Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer.

Drost FH, Osses DF, Nieboer D, Steyerberg EW, Bangma CH, Roobol MJ, Schoots IG.

Cochrane Database Syst Rev. 2019 Apr 25;4:CD012663. doi: 10.1002/14651858.CD012663.pub2. Review.

PMID:
31022301
6.

Multiparametric magnetic resonance imaging in the detection of prostate cancer.

Durmus T, Baur A, Hamm B.

Aktuelle Urol. 2014 Mar;45(2):119-26. doi: 10.1055/s-0034-1371875. Epub 2014 Apr 3. Review.

PMID:
24700068
7.

Multiparametric magnetic resonance imaging in the detection of prostate cancer.

Durmus T, Baur A, Hamm B.

Rofo. 2014 Mar;186(3):238-46. doi: 10.1055/s-0034-1365937. Epub 2014 Jan 22. Review.

8.

[Multiparametric MRI for prostate cancer screening].

Hoeks CM, Fütterer JJ, Somford DM, van Oort IM, Huisman H, Barentsz JO.

Ned Tijdschr Geneeskd. 2009;153:B487. Review. Dutch.

PMID:
20003566
9.

MRI in prostate cancer diagnosis: do we need to add standard sampling? A review of the last 5 years.

Stabile A, Giganti F, Emberton M, Moore CM.

Prostate Cancer Prostatic Dis. 2018 Nov;21(4):473-487. doi: 10.1038/s41391-018-0071-8. Epub 2018 Aug 13. Review.

PMID:
30104656
10.

Integration of multiparametric MRI into active surveillance of prostate cancer.

Holtz JN, Tay KJ, Polascik TJ, Gupta RT.

Future Oncol. 2016 Nov;12(21):2513-2529. Epub 2016 Jun 20. Review.

PMID:
27322161
11.

Multiparametric magnetic resonance imaging: Current role in prostate cancer management.

Ueno Y, Tamada T, Bist V, Reinhold C, Miyake H, Tanaka U, Kitajima K, Sugimura K, Takahashi S.

Int J Urol. 2016 Jul;23(7):550-7. doi: 10.1111/iju.13119. Epub 2016 May 17. Review.

12.

Multiparametric-MRI in diagnosis of prostate cancer.

Ghai S, Haider MA.

Indian J Urol. 2015 Jul-Sep;31(3):194-201. doi: 10.4103/0970-1591.159606. Review.

13.

Multiparametric-MRI-Guided Biopsy in the Era of Precision Medicine.

Bergero MA, Martínez PF, Radtke JP, Hadaschik BA.

Arch Esp Urol. 2017 Dec;70(10):833-844. Review. Spanish, English.

PMID:
29205162
14.

A critical comparison of techniques for MRI-targeted biopsy of the prostate.

Giganti F, Moore CM.

Transl Androl Urol. 2017 Jun;6(3):432-443. doi: 10.21037/tau.2017.03.77. Review.

15.

Multiparametric MRI in biopsy guidance for prostate cancer: fusion-guided.

Rothwax JT, George AK, Wood BJ, Pinto PA.

Biomed Res Int. 2014;2014:439171. doi: 10.1155/2014/439171. Epub 2014 Jul 13. Review.

16.

Multiparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer: A Systematic Review.

Haider MA, Yao X, Loblaw A, Finelli A.

Clin Oncol (R Coll Radiol). 2016 Sep;28(9):550-67. doi: 10.1016/j.clon.2016.05.003. Epub 2016 May 30. Review.

PMID:
27256655
17.

[Multiparametric MRI of the prostate : Important radiological findings for urologists].

Schlemmer HP.

Radiologe. 2017 Aug;57(8):621-630. doi: 10.1007/s00117-017-0277-0. Review. German.

PMID:
28667392
18.

Current role of multiparametric magnetic resonance imaging for prostate cancer.

Loffroy R, Chevallier O, Moulin M, Favelier S, Genson PY, Pottecher P, Crehange G, Cochet A, Cormier L.

Quant Imaging Med Surg. 2015 Oct;5(5):754-64. doi: 10.3978/j.issn.2223-4292.2015.10.08. Review.

19.

What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel.

Moldovan PC, Van den Broeck T, Sylvester R, Marconi L, Bellmunt J, van den Bergh RCN, Bolla M, Briers E, Cumberbatch MG, Fossati N, Gross T, Henry AM, Joniau S, van der Kwast TH, Matveev VB, van der Poel HG, De Santis M, Schoots IG, Wiegel T, Yuan CY, Cornford P, Mottet N, Lam TB, Rouvière O.

Eur Urol. 2017 Aug;72(2):250-266. doi: 10.1016/j.eururo.2017.02.026. Epub 2017 Mar 21. Review.

PMID:
28336078
20.

Multiparametric MRI in the Detection of Clinically Significant Prostate Cancer.

Fütterer JJ.

Korean J Radiol. 2017 Jul-Aug;18(4):597-606. doi: 10.3348/kjr.2017.18.4.597. Epub 2017 May 19. Review.

Supplemental Content

Support Center